![]() Listening, discerning, negotiating, and finding common interests.” “Life Sciences investing is not just about recognizing good science,” Papiernik says, “it’s about people - learning how to interact with co-investors, limited partners, and entrepreneurs. Scott and his team at LSI have conducted numerous market research projects for top medical device manufacturers including Johnson & Johnson, Medtronic, Boston Scientific, Abbott, Becton Dickinson, Teleflex, Cardinal Health, GE Healthcare, and Stryker, among others.Īntoine Papiernik is Chairman and Managing Partner at Sofinnova Partners, which he joined in 1997. ![]() ![]() He has held leadership roles as a strategic partner for Elsevier Business Intelligence, Health Research Intelligence, and Informa Business Intelligence. Prior to founding LSI, he held senior executive roles with renowned life science data providers including Medical Data International, Medtech Insight and Windhover Information. ![]() He has been in the medtech market intelligence business for over 20 years supporting venture funded startups, major strategics, and life science investors as they navigate the ever-changing medtech marketplace. Scott is the President, CEO and Founder of Life Science Intelligence. Scott's mission at the meeting will be to connect the investors, innovators and strategics that are driving the future of medtech. Scott will join his team of exclusive sponsors to host the Emerging Medtech Summit.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |